Analyst Downgrades: GoPro Inc, Valeant Pharmaceuticals Intl Inc, and Apple Inc.

Analysts downwardly revised their ratings on GoPro Inc (NASDAQ:GPRO), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and Apple Inc. (NASDAQ:AAPL)

Dec 14, 2015 at 9:29 AM
facebook X logo linkedin


Analysts are weighing in on action camera maker GoPro Inc (NASDAQ:GPRO), drugmaker Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and tech titan Apple Inc. (NASDAQ:AAPL)Here's a quick roundup of today's bearish brokerage notes on GPRO, VRX, and AAPL.

  • GPRO is set to drop 6% this morning, after the shares were hit with another downgrade. This time it was Morgan Stanley who weighed in, reducing its outlook to "underweight" from "equal weight," and slashing its price target to $12 from $23. More downgrades could be forthcoming for GoPro Inc, since the majority of analysts still rate it a "buy" or better. The equity has dropped almost 70% in 2015, settling at $19.15 on Friday. 
  • VRX is edging higher in pre-market trading, even though RBC cut its price target to $194 from $206. Then again, this still represents more than twice the security's current level, last seen at $93.06. The stock has dropped over 57% in the past three months in the wake of Citron Research's short-seller report. As a result, Valeant Pharmaceuticals Intl Inc has reportedly hired an attorney, as well as public relations specialists. Option traders are hoping the shares can make up some of their lost ground. VRX's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands at 2.75, which ranks higher than 89% of all comparable readings from the past year. 
  • AAPL got hit with a price-target cut to $150 from $155 at Barclays, and is now looking at a 1.3% drop out of the gate. In addition, Morgan Stanley trimmed its target to $143 from $152, citing an expected drop in iPhone unit sales. The shares closed last week at $113.18, hanging on to a 2.5% year-to-date lead. Most other analysts maintain a bullish outlook for Apple Inc. Twenty-two of the 31 brokerage firms with coverage on the stock say it's a "buy" or better, and AAPL's average 12-month price target of $148.31 stands in never-before-charted territory. 
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI